>
>

Atherectomy Devices Market – By Product, By Application, By End Use – Global Forecast, 2025 to 2034

Download Free PDF

Atherectomy Devices Market Size

The global atherectomy devices market size was valued at USD 794.6 million in 2024 and is expected to exhibit growth at a CAGR of 6.8% from 2025 to 2034. The market is driven by the increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), growing aging populations, sedentary lifestyles, and rising incidences of diabetes and obesity.
 

Atherectomy Devices Market

Advances in minimally invasive procedures, coupled with the development of technologically sophisticated atherectomy devices, such as laser and orbital atherectomy systems, have improved procedural outcomes, enhancing adoption rates.
 

The growing awareness among patients and healthcare professionals regarding the advantages of atherectomy, such as reduced restenosis rates and improved blood flow, further propels market growth. Favorable medical devices reimbursement policies for peripheral vascular interventions, particularly in developed regions, support increased utilization of these devices. Rising investments in healthcare infrastructure in emerging economies, coupled with expanding medical tourism, are also fueling market expansion.
 

Moreover, ongoing innovations by key manufacturers, such as the integration of real-time imaging and artificial intelligence to optimize procedural accuracy, continue to improve clinical efficacy and patient outcomes. The growing preference for outpatient procedures and ambulatory surgical centers due to cost efficiency and convenience is also driving the demand for atherectomy devices.
 

Additionally, the increasing number of regulatory approvals and clinical trials that demonstrate the safety and efficacy of novel atherectomy systems encourage broader adoption. Overall, the interplay of technological advancements, patient-centric healthcare trends, and demographic shifts sustains the robust growth trajectory of the atherectomy devices market.  
 

Atherectomy devices are specialized medical instruments designed to remove atherosclerotic plaque from blood vessels, restoring blood flow in patients with conditions such as peripheral artery disease (PAD) or coronary artery disease (CAD). These devices use various mechanisms, including cutting, shaving, grinding, or vaporizing, to excise or reduce plaque buildup without the need for major surgery.
 

Atherectomy Devices Market Trends

The increasing preference for minimally invasive procedures is a significant driver of the global market. These procedures offer numerous advantages over traditional surgical interventions, including reduced trauma, shorter recovery times, and lower risk of complications, making them highly appealing to both patients and healthcare providers.
 

  • Atherectomy, as a minimally invasive technique, is particularly effective for removing atherosclerotic plaque in peripheral and coronary arteries, providing an alternative to more invasive bypass surgeries. The development of advanced atherectomy devices, such as directional, rotational, orbital, and laser atherectomy systems, has further enhanced procedural precision and safety, encouraging broader adoption. These devices enable targeted plaque removal while minimizing damage to surrounding tissues, making them suitable for patients with complex or high-risk conditions.
     
  • Patient awareness campaigns highlighting the benefits of minimally invasive treatments and favorable reimbursement policies in developed regions also contribute to market growth. As healthcare systems globally shift toward cost-effective and patient-centric care models, the emphasis on minimally invasive procedures is expected to intensify, further propelling the market.  
     

Atherectomy Devices Market Analysis

Atherectomy Devices Market, By Product, 2021-2034 (USD Million)

Based on product, the market is segmented as orbital atherectomy devices, laser atherectomy devices, directional atherectomy devices, and rotational atherectomy devices. The orbital atherectomy devices segment is expected to drive business growth and expand at a CAGR of 6.6%, reaching over USD 468.2 million by 2034.
 

  • These devices offer enhanced procedural precision and efficiency by utilizing a spinning crown or burr to safely sand away plaque without damaging the arterial walls. Their ability to provide consistent and uniform plaque removal in both peripheral and coronary arteries has made them a preferred choice for clinicians, particularly in complex cases. The rising prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD) globally has amplified the demand for advanced atherectomy solutions, further bolstering the adoption of orbital systems.
     
  • Technological advancements, such as the integration of real-time imaging and advanced lubrication techniques, enhance device performance and safety, driving greater utilization. The expanding availability of outpatient and ambulatory surgical centers equipped with minimally invasive technologies also supports the segmental growth.  
     

Based on application, the atherectomy devices market is segmented as peripheral vascular applications and coronary applications. The peripheral vascular applications segment is expected to drive business growth and expand at a CAGR of 6.3%, reaching USD 1.1 billion by 2034.
 

  • PAD significantly impacts mobility and quality of life, creating a strong demand for effective treatments like atherectomy. Minimally invasive atherectomy procedures offer advantages such as reduced hospital stays, quicker recovery, and fewer complications compared to traditional surgical approaches, making them increasingly preferred by patients and clinicians.
     
  • Technological advancements in atherectomy devices, including rotational, directional, and orbital systems, enhance precision and safety, further boosting adoption. The integration of imaging technologies and real-time feedback in these devices allows for targeted plaque removal, improving outcomes in complex cases.
     
  • Additionally, the expansion of outpatient and ambulatory surgical centers equipped with advanced vascular intervention capabilities is facilitating greater access to these treatments. Favorable reimbursement policies in developed regions and rising healthcare investments in emerging markets are further driving the segment growth.
     
Atherectomy Devices Market, By End Use (2024)

Based on end use, the atherectomy devices market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 61.5% in 2024.
 

  • Hospitals are typically the primary healthcare facilities for treating complex cardiovascular conditions such as peripheral artery disease (PAD) and coronary artery disease (CAD), where atherectomy procedures are commonly performed. The availability of specialized medical staff, advanced infrastructure, and comprehensive patient care in hospitals supports the adoption of atherectomy devices.
     
  • Additionally, hospitals are equipped with state-of-the-art imaging and diagnostic technologies that aid in the precise placement and operation of atherectomy devices, ensuring better outcomes. Furthermore, the higher volume of patients in hospitals and the growing incidence of cardiovascular diseases are significant factors propelling the demand for these devices.
     
  • Hospitals also benefit from favorable reimbursement policies and insurance coverage for advanced cardiovascular interventions, making these procedures more accessible to patients. The integration of multi-disciplinary teams, including cardiologists, vascular surgeons, and interventional radiologists, further promotes the use of atherectomy devices in hospitals.
     
U.S. Atherectomy Devices Market, 2021 – 2034 (USD Million)

U.S. atherectomy devices market accounted for USD 432.6 million in 2024 and is anticipated to grow at a CAGR of 6.2% between 2025 to 2034 period.
 

  • A key driver is the rising prevalence of cardiovascular diseases, including peripheral artery disease (PAD) and coronary artery disease (CAD), due to aging populations, sedentary lifestyles, and increasing rates of diabetes and obesity. As these conditions become more common, the demand for effective, minimally invasive treatment options, such as atherectomy, is growing. The development of advanced atherectomy devices that offer greater precision, enhanced safety, and shorter recovery times is further boosting their adoption. Additionally, the increasing preference for outpatient procedures and the growing number of ambulatory surgical centers in the U.S. are contributing to market growth. The strong healthcare infrastructure and favorable reimbursement policies in the U.S. also support the widespread use of these devices.
     
  • Furthermore, ongoing advancements in technology, including the integration of imaging guidance and robotics in atherectomy procedures, are improving procedural efficiency and patient outcomes.
     
  • The U.S. is also home to leading manufacturers of atherectomy devices, ensuring a continuous flow of innovation and enhancing market growth.
     

UK atherectomy devices market is projected to grow remarkably in the coming years.
 

  • The rising prevalence of cardiovascular diseases, including peripheral artery disease (PAD) and coronary artery disease (CAD), particularly among the aging population, is one of the key drivers. As the population ages, the demand for effective treatment options like atherectomy devices is increasing, particularly as the need for minimally invasive procedures grows. The UK’s strong healthcare infrastructure, with advanced hospitals and specialized cardiovascular centers, further supports the adoption of atherectomy devices.
     
  • Additionally, the National Health Service (NHS) has been gradually increasing its focus on providing cost-effective and minimally invasive treatment options, making atherectomy a viable solution for many patients. The government’s support through favorable reimbursement policies and healthcare initiatives aimed at reducing surgery-related complications also contributes to market growth.
     
  • The rise in public awareness about the benefits of early diagnosis and treatment of cardiovascular diseases also plays a role in encouraging patients to opt for atherectomy procedures.
     

China holds a dominant position in the Asia Pacific atherectomy devices market.
 

  • The country has witnessed a significant rise in the prevalence of cardiovascular diseases, driven by an aging population, urbanization, and increasing rates of lifestyle-related risk factors such as smoking, unhealthy diets, and obesity. These factors have resulted in a higher demand for advanced cardiovascular treatments, including atherectomy procedures. China's healthcare system has also been improving rapidly, with substantial investments in medical infrastructure and technology, making advanced devices like atherectomy systems more accessible.
     
  • Additionally, government initiatives to improve healthcare services, coupled with a growing focus on minimally invasive treatments, are pushing the adoption of atherectomy devices in the country. Hospitals in China are increasingly adopting modern interventional technologies to treat patients with peripheral artery disease and coronary artery disease, further driving market growth.
     
  • The presence of local manufacturers and collaborations with international medical device companies also contribute to market growth by enhancing affordability and expanding the availability of atherectomy devices in China.
     

Atherectomy Devices Market Share

The market is highly competitive, with key players holding significant market share. Major companies such as Medtronic, Boston Scientific, Philips, and Cardiovascular Systems dominate the market, offering advanced atherectomy systems that cater to a wide range of cardiovascular conditions. Medtronic, with its robust portfolio of rotational and orbital atherectomy devices, holds a substantial market share, followed by Boston Scientific with its innovative laser atherectomy technologies. Market players focus on strategic initiatives such as mergers, acquisitions, partnerships, and product innovations to strengthen their market position and expand their reach across global regions, particularly in emerging markets.
 

Atherectomy Devices Market Companies

Prominent players operating in the atherectomy devices industry include:

  • Abbott
  • angiodynamics
  • AVINGER
  • B. Braun
  • BD (Becton, Dickinson and Company)
  • BIOMERICS
  • Boston Scientific
  • Cardinal Health
  • Cardiovascular Systems
  • Cordis
  • Philips
  • Medtronic
  • Nipro
  • Rex Medical
  • TERUMO
     

Atherectomy Devices Industry News:

  • In February 2023, Abbott signed a formal agreement to purchase Cardiovascular Systems Inc., a medical device business that develops novel atherectomy systems utilized in the treatment of peripheral and coronary artery diseases.
     

The atherectomy devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Product

  • Orbital atherectomy devices
  • Laser atherectomy devices
  • Directional atherectomy devices
  • Rotational atherectomy devices

Market, By Application

  • Peripheral vascular applications
  • Coronary applications

Market, By End Use

  • Hospitals
  • Ambulatory surgical centers
  • Other end users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Mariam Faizullabhoy , Gauri Wani
Frequently Asked Question(FAQ) :
Who are some of the prominent players in the atherectomy devices industry?
Key players in the market include Abbott, Angiodynamics, Avinger, B. Braun, BD (Becton, Dickinson and Company), Biomerics, Boston Scientific, Cardinal Health, Cardiovascular Systems, Cordis, Philips, Medtronic, Nipro, Rex Medical, and Terumo.
What is the size of the U.S. atherectomy devices industry?
Which product segment is driving growth in the atherectomy devices industry?
How big is the atherectomy devices market?
Atherectomy Devices Market Scope
  • Atherectomy Devices Market Size
  • Atherectomy Devices Market Trends
  • Atherectomy Devices Market Analysis
  • Atherectomy Devices Market Share
Related Reports
    Authors: Mariam Faizullabhoy , Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2024

    Companies covered: 15

    Tables & Figures: 130

    Countries covered: 19

    Pages: 145

    Download Free PDF

    Top